Publications:

Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy.

Cancer Cell

Fang, Yong Y; McGrail, Daniel J DJ; Sun, Chaoyang C; Labrie, Marilyne M; Chen, Xiaohua X; Zhang, Dong D; Ju, Zhenlin Z; Vellano, Christopher P CP; Lu, Yiling Y; Li, Yongsheng Y; Jeong, Kang Jin KJ; Ding, Zhiyong Z; Liang, Jiyong J; Wang, Steven W SW; Dai, Hui H; Lee, Sanghoon S; Sahni, Nidhi N; Mercado-Uribe, Imelda I; Kim, Tae-Beom TB; Chen, Ken K; Lin, Shiaw-Yih SY; Peng, Guang G; Westin, Shannon N SN; Liu, Jinsong J; O'Connor, Mark J MJ; Yap, Timothy A TA; Mills, Gordon B GB

Publication Date: 2019-06-10

Variant appearance in text: ERBB2: T126C

PubMed Link: 31185210

Variant Present in the following documents:

• Main text

View BVdb publication page